Abstract
Maintenance of atrial fibrillation is a complex mechanism, including extensive electrical and structural remodeling of the atria which involves progressive fibrogenesis. Galectin-3 is a biomarker of fibrosis, and, thus, may be involved in atrial remodeling in atrial fibrillation patients. We review the role of galectin-3 in AF mechanisms and its potential therapeutic implications.
Author supplied keywords
Cite
CITATION STYLE
Clementy, N., Piver, E., Bisson, A., Andre, C., Bernard, A., Pierre, B., … Babuty, D. (2018, April 1). Galectin-3 in atrial fibrillation: Mechanisms and therapeutic implications. International Journal of Molecular Sciences. MDPI AG. https://doi.org/10.3390/ijms19040976
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.